Mode
Text Size
Log in / Sign up
N/A Completed N=49 Randomized Single-blind

On-Eye Evaluation of Contact Lens Axis Location

Myopia · Astigmatism · Refractive error
Source: ClinicalTrials.gov NCT02100410 ↗
Enrolled (actual)
49
Serious AEs
0.0%
Results posted
May 2014
Primary outcomePrimary: Percentage of Lenses With Axis Orientation ≤ 10 Degrees From Ideal Location After 3 Minutes of Wear — 24.5; 46.9; 36.7 percentage of lenses

Summary

The purpose of this study was to evaluate the axis location of toric contact lenses after 3 minutes of wear. During this 1-visit study, each participant wore 3 pairs of study lenses of various design iterations (2-87-1, 2-87-2, 2-87-3) for an exposure time of approximately 30 minutes each. Each pair consisted of lenses of the same design iteration, 1 lens with embossed mark [TEST1 (T1), TEST3 (T3), TEST5 (T5)], worn on the right eye, and 1 lens without embossed mark [TEST2 (T2), TEST4 (T4), and TEST6 (T6)] worn on the left eye.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Lenses With Axis Orientation ≤ 10 Degrees From Ideal Location After 3 Minutes of Wear
24.5; 46.9; 36.7 —
SECONDARY
Lens Awareness
0.6; 0.2; 0.4; 0.2; 1.0; 0.6 —
SECONDARY
Handling on Removal
8.0; 7.8; 8.9 —

Eligibility Criteria

Inclusion Criteria

  • Sign written Informed Consent.
  • Best corrected distance visual acuity greater than or equal to 20/25 in each eye.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • History of any ocular surgery or ocular injury within 12 weeks of enrollment for this study.
  • Anterior segment disease, infection, inflammation, or abnormality that contraindicates contact lens wear.
  • History of herpetic keratitis.
  • Slit-lamp findings at baseline as specified in the protocol.
  • Any use of systemic or ocular medications for which contact lens wear could be contraindicated, including ocular medications that require instillation during contact lens wear.
  • Clinically significant dry eye not responding to treatment.
  • History of refractive surgery.
  • Other protocol-defined exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02100410). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search